BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Principi M, Cassano N, Contaldo A, Iannone A, Losurdo G, Barone M, Mastrolonardo M, Vena GA, Ierardi E, Di Leo A. Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association. World J Gastroenterol 2016; 22(20): 4802-4811 [PMID: 27239107 DOI: 10.3748/wjg.v22.i20.4802] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 28] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Hwang J, Rick J, Hsiao J, Hamzavi IH, Shi VY. Microbiome in Hidradenitis Suppurativa: Current Evidence and Practice. Curr Derm Rep. [DOI: 10.1007/s13671-021-00349-y] [Reference Citation Analysis]
2 Gürtler A, Schmitt L. Der Einfluss der Ernährung bei entzündlichen Gesichtsdermatosen. J Dtsch Dermatol Ges 2022;20:185-204. [PMID: 35146875 DOI: 10.1111/ddg.14683_g] [Reference Citation Analysis]
3 Gürtler A, Laurenz S. The impact of clinical nutrition on inflammatory skin diseases. J Dtsch Dermatol Ges 2022. [PMID: 35088524 DOI: 10.1111/ddg.14683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bezzio C, Della Corte C, Vernero M, Di Luna I, Manes G, Saibeni S. Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations. Therap Adv Gastroenterol 2022;15:175628482211153. [DOI: 10.1177/17562848221115312] [Reference Citation Analysis]
5 Mahmud MR, Akter S, Tamanna SK, Mazumder L, Esti IZ, Banerjee S, Akter S, Hasan MR, Acharjee M, Hossain MS, Pirttilä AM. Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases. Gut Microbes 2022;14:2096995. [PMID: 35866234 DOI: 10.1080/19490976.2022.2096995] [Reference Citation Analysis]
6 Katzman JH, Tahmasbi M, Ghayouri M, Nanjappa S, Li MC, Greene J. Management of Severe Hidradenitis Suppurativa. Cureus 2021;13:e13483. [PMID: 33777570 DOI: 10.7759/cureus.13483] [Reference Citation Analysis]
7 Chiricozzi A, Giovanardi G, Caposiena Caro DR, Iannone M, De Simone C, Cannizzaro MV, Oranges T, Fossati B, Di Matteo E, Dini V, Bianchi L, Peris K. Characterization of comorbid conditions burdening hidradenitis suppurativa: a multicentric observational study. G Ital Dermatol Venereol 2020;155. [DOI: 10.23736/s0392-0488.18.06165-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa. Journal of the American Academy of Dermatology 2020;82:1045-58. [DOI: 10.1016/j.jaad.2019.08.090] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 17.5] [Reference Citation Analysis]
9 Ainouche A, Durot C, Soyer P, Kianmanesh R, Mulé S, Hoeffel C. Unusual intestinal and extra intestinal findings in Crohn's disease seen on abdominal computed tomography and magnetic resonance enterography. Clinical Imaging 2020;59:30-8. [DOI: 10.1016/j.clinimag.2019.04.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Capron M, Béghin L, Leclercq C, Labreuche J, Dendooven A, Standaert A, Delbeke M, Porcherie A, Nachury M, Boruchowicz A, Dupas JL, Fumery M, Paupard T, Catteau S, Deplanque D, Colombel JF, Desreumaux P. Safety of P28GST, a Protein Derived from a Schistosome Helminth Parasite, in Patients with Crohn's Disease: A Pilot Study (ACROHNEM). J Clin Med 2019;9:E41. [PMID: 31878146 DOI: 10.3390/jcm9010041] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
11 Polkowska‐pruszyńska B, Gerkowicz A, Krasowska D. The gut microbiome alterations in allergic and inflammatory skin diseases – an update. J Eur Acad Dermatol Venereol 2019;34:455-64. [DOI: 10.1111/jdv.15951] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
12 Principi M, Iannone A, Losurdo G, Mangia M, Shahini E, Albano F, Rizzi SF, La Fortezza RF, Lovero R, Contaldo A, Barone M, Leandro G, Ierardi E, Di Leo A. Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors. Inflamm Bowel Dis. 2018;24:1589-1596. [PMID: 29688336 DOI: 10.1093/ibd/izy051] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 12.3] [Reference Citation Analysis]
13 Silfvast-Kaiser A, Youssef R, Paek SY. Diet in hidradenitis suppurativa: a review of published and lay literature. Int J Dermatol 2019;58:1225-30. [PMID: 31006861 DOI: 10.1111/ijd.14465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ribaldone DG, Pellicano R, Actis GC. The gut and the inflammatory bowel diseases inside-out: extra-intestinal manifestations. Minerva Gastroenterol Dietol 2019;65:309-18. [PMID: 30994321 DOI: 10.23736/S1121-421X.19.02577-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 4.7] [Reference Citation Analysis]
15 Frew JW, Hawkes JE, Krueger JG. Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms. Ther Adv Chronic Dis 2019;10:2040622319830646. [PMID: 30854183 DOI: 10.1177/2040622319830646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
16 Sprouse ML, Bates NA, Felix KM, Wu HJ. Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells. Immunology 2019;156:305-18. [PMID: 30560993 DOI: 10.1111/imm.13037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
17 Maarouf M, Platto JF, Shi VY. The role of nutrition in inflammatory pilosebaceous disorders: Implication of the skin-gut axis. Australas J Dermatol 2019;60:e90-8. [PMID: 30175843 DOI: 10.1111/ajd.12909] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
18 Melnik BC, John SM, Chen W, Plewig G. T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities. Br J Dermatol 2018;179:260-72. [PMID: 29573406 DOI: 10.1111/bjd.16561] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
19 Giovanardi G, Chiricozzi A, Bianchi L, De simone C, Dini V, Franceschini C, Garcovich S, Oranges T, Di raimondo C, Caposiena caro D, Romanelli M, Peris K. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis. Dermatology 2018;234:66-70. [DOI: 10.1159/000487799] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
20 Fleisher M, Marsal J, Lee SD, Frado LE, Parian A, Korelitz BI, Feagan BG. Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease. Dig Dis Sci 2018;63:825-33. [PMID: 29484571 DOI: 10.1007/s10620-018-4971-1] [Cited by in Crossref: 49] [Cited by in F6Publishing: 37] [Article Influence: 12.3] [Reference Citation Analysis]
21 Ramos-rodriguez AJ, Timerman D, Khan A, Bonomo L, Hunjan MK, Lemor A. The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014. Int J Dermatol 2018;57:547-52. [DOI: 10.1111/ijd.13932] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
22 Dequidt L, Cogrel O, Guillet S, Milpied B, Darrigade A, Beylot‐barry M, Pham‐ledard A. Paradoxical psoriasiform reactions to antitumour necrosis factor‐α drugs in hidradenitis suppurativa. Br J Dermatol 2018;178:281-3. [DOI: 10.1111/bjd.15616] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
23 Thomi R, Yerly D, Yawalkar N, Simon D, Schlapbach C, Hunger RE. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa. Br J Dermatol 2017;177:1358-66. [PMID: 28301691 DOI: 10.1111/bjd.15458] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
24 Ergun T. Hidradenitis suppurativa and the metabolic syndrome. Clin Dermatol 2018;36:41-7. [PMID: 29241751 DOI: 10.1016/j.clindermatol.2017.09.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
25 Thomi R, Kakeda M, Yawalkar N, Schlapbach C, Hunger RE. Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2017;31:2091-6. [PMID: 28602023 DOI: 10.1111/jdv.14389] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
26 Richter L, Rappersberger K. [Cutaneous involvement in chronic inflammatory bowel disease : Crohn's disease and ulcerative colitis]. Hautarzt 2016;67:940-7. [PMID: 27830291 DOI: 10.1007/s00105-016-3894-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
27 Egeberg A, Jemec GBE, Kimball AB, Bachelez H, Gislason GH, Thyssen JP, Mallbris L. Prevalence and Risk of Inflammatory Bowel Disease in Patients with Hidradenitis Suppurativa. J Invest Dermatol 2017;137:1060-4. [PMID: 28089682 DOI: 10.1016/j.jid.2016.11.040] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 8.4] [Reference Citation Analysis]
28 Tursi A. Concomitant hidradenitis suppurativa and pyostomatitis vegetans in silent ulcerative colitis successfully treated with golimumab. Dig Liver Dis 2016;48:1511-2. [PMID: 27793616 DOI: 10.1016/j.dld.2016.09.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]